Join the global vascular and endovascular community

Charing Cross (CX) Symposium 2027 returns for its 49th year on 6 – 8 April 2027 at Olympia, London. Come and join us as we welcome the largest international community of clinicians, educators, innovators and industry partners in vascular disease management.

Across three days, CX Symposium will feature a physician-led scientific programme built around lively debate, peer-to-peer exchange, and an audience as expert as those presenting. With 500+ presentations, 300+ discussions, hands-on workshops, podium-first data, live and edited cases and an exhibition, CX Symposium brings together international speakers and the future leaders of vascular care to interrogate the evolving evidence base and its practical implications for best patient outcomes.

Registration opens soon.

CX Co-Chairs

Dittmar Böckler
Dittmar BöcklerHeidelberg, Germany
Andrew Holden
Andrew HoldenAuckland, New Zealand
Erin Murphy
Erin MurphyCharlotte, United States

2026 On-Demand

CX Symposium News

FAQs

Latest CX news

Insights into acute stroke challenges

March 4th, 2016|Comments Off on Insights into acute stroke challenges

Ross Naylor (Leicester, UK), member of the CX Programme Organising Board, discusses the biggest challenges of treating acute stroke and the role of a multidisciplinary team in this setting. Ross Naylor What do [...]

Long-term data needed for deep venous disease treatment

February 26th, 2016|Comments Off on Long-term data needed for deep venous disease treatment

Stephen Black (London, UK), member of the CX Programme Organising Board, speaks about the current challenges in the treatment of deep venous disease, key developments in the field, and factors influencing outcomes in venous stenting. [...]

Superficial venous treatment: techniques and applications

February 26th, 2016|Comments Off on Superficial venous treatment: techniques and applications

Mark Whiteley (London, UK), member of the CX Programme Organising Board, discusses various techniques for superficial venous disease treatment and their applications to specific patients. The latest evidence on this area will be discussed at [...]